Dr. Pawan Kumar Singh

Dr. Pawan Kumar Singh is a distinguished Haemato-Oncologist and Bone Marrow Transplant (BMT) specialist with over 15 years of extensive clinical experience. He completed his DM in Clinical Haematology from the All India Institute of Medical Sciences (AIIMS), New Delhi, one of the most prestigious medical institutions in the country.
Dr. Singh is internationally recognized for his pioneering work in Haematopoietic Stem Cell Transplantation (HSCT), particularly in autoimmune disorders. He is credited with performing the highest number of stem cell transplants for autoimmune diseases, especially Multiple Sclerosis. Over the course of his career, he has successfully carried out 1,000+ blood and marrow transplants, including Matched Sibling Donor (MSD), Matched Unrelated Donor (MUD), and Haploidentical transplants, in both adult and pediatric patients.
In addition to transplant medicine, Dr. Singh and his multidisciplinary team have developed strong expertise in the management of paediatric solid tumors. He has contributed extensively to academic research, with multiple publications in reputed national and international medical journals, and continues to remain actively engaged in advanced research within the field of haematology.
Professional Experience
Director – Department of Hematology & Bone Marrow Transplant, Shalby Sanar International Hospital, Gurugram
Director – Centre for Bone Marrow Transplant, BLK-Max Super Speciality Hospital, New Delhi
Senior Consultant & Head – Hemato-Oncology and BMT, Artemis Hospital, Gurugram
Associate Consultant – Hemato-Oncology & BMT, Jaypee Hospital, Noida
Senior Resident – Department of Hematology, AIIMS, New Delhi
Senior Registrar – Department of Hematology, Christian Medical College, Vellore
Professional Memberships
Indian Society of Hematology & Blood Transfusion
European Haematology Association
Education
DM – Clinical Haematology
MD
MBBS
Areas of Special Interest & Expertise
Management of Leukemia, Lymphoma, and Multiple Myeloma
High-dose and induction chemotherapy (AML, ALL, MPAL)
Targeted and immunotherapies for blood cancers
Allogeneic Bone Marrow Transplantation (MSD, MUD, Haplo)
Autologous BMT for autoimmune diseases, especially Multiple Sclerosis
High-risk and complex BMT cases
Bone Marrow Transplantation in special clinical situations (Jehovah’s Witnesses, HIV, viral infections, CKD on dialysis)
Thalassemia and Sickle Cell Disease
Graft manipulation and T-cell depletion in Haploidentical BMT
CAR-T Cell Therapy